Detection of t(14;18) in follicular lymphoma by dual-color fluorescence in situ hybridization on paraffin-embedded tissue sections

Cancer Genetics and Cytogenetics

Volumn 150, Issue 1, 2004, Pages 22-26

  Matsumoto, Yosuke ^a   Nomura, Kenichi ^a   Matsumoto, Sawako ^a   Ueda, Kyoji ^a   Nakao, Mitsushige ^a   Nishida, Kazuhiro ^a   Sakabe, Hideaki ^b   Yokota, Shohei ^a   Horiike, Shigeo ^a   Nakamine, Hirokazu ^c   Nakamura, Shigeo ^d   Taniwaki, Masafumi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Kohka Public Hospital   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PARAFFIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EVALUATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM STAGING; PARAFFIN EMBEDDING; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSLOCATION, GENETIC;

EID: 12144289954     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.08.008     Document Type: Article

References (35)

1. Fukuhara S., Rowley J.D., Variakojis D., Golomb H.M. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res. 39:1992;3119-3128.
2. Tsujimoto Y., Finger L.R., Yunis J., Nowell P.C., Croce C.M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 226:1984;1097-1099.
3. H on chromosome 14 and near a transcriptional unit on 18. Cell. 41:1985;899-906.
4. Cleary M.L., Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster resion near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA. 82:1985;7439-7443.
5. Yunis J.J., Frizzera G., Oken M.M., McKenna J., Theologides A., Arnesen M. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med. 316:1987;79-84.
6. Rowley J.D. Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation. J Clin Oncol. 6:1988;919-925.
7. Taniwaki M., Sliverman G.A., Nishida K., Horiike S., Misawa S., Shimazaki C., Miura I., Nagai M., Abe M., Fukuhara S., Horiike S., Misawa S., Shimazaki C., Miura I., Nagai M., Abe M., Fukuhara S., Kashima K. Translocations and amplification of the BCL2 gene are detected in interphase nuclei of non-Hodgkin's lymphoma by in situ hybridization with yeast artificial chromosome clones. Blood. 86:1995;1481-1486.
8. Kneba M., Eick S., Herbst H., Willigeroth S., Pott C., Bolz I., Bergholz M., Neumann C., Stein H., Krieger G. Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing. Cancer Res. 51:1991;3243-3250.
9. Corbally N., Grogan L., Dervan P.A., Carney D.N. The detection of specific gene rearrangements in non-Hodgkin's lymphoma using the polymerase chain reaction. Br J Cancer. 66:1992;805-809.
10. Weiss L.M., Warnke R.A., Sklar J., Cleary M.L. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med. 317:1987;1185-1189.
11. Amakawa R., Fukuhara S., Ohno H., Doi S., Oguma S., Tanabe S., Yamabe H., Edamura S., Tomono N., Nasu K. Involvement of bcl-2 gene in Japanese follicular lymphoma. Blood. 73:1989;787-791.
12. Seto M., Osada H., Ueda R., Ito C., Iwaki O., Oyama A., Suchi T., Takahashi T. bcl-2 translocation in Japanese B cell lymphoma: novel bcl-2 translocation with immunoglobulin heavy chain diversity segment. Jpn J Cancer Res. 82:1991;65-71.
13. Segel M.J., Paltiel O., Zimran A., Gottschalk-Sabag S., Schibi G., Krichevski S., Ludkovski O., Yehuda D.B. Geographic variance in the frequency of the t(14;18) translocation in follicular lymphoma: an Israeli series compared to the world. Blood Cells Mol Dis. 24:1988;62-72.
14. Liu Y., Hernandez A.M., Shibata D., Cortopassi G.A. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA. 91:1994;8910-8914.
15. Limpens J., Stad R., Vos C., de Vlaam C., de Jong D., van Ommen G.J., Schuuring E., Kluin P.M. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood. 85:1995;2528-2536.
16. Dolken G., Illerhaus G., Hirt C., Mertelsmann R. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol. 14:1996;1333-1344.
17. Limpens J., de Jong D., van Krieken J.H., Price C.G., Young B.D., van Ommen G.J., Kluin P.M. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene. 6:1991;2271-2276.
18. Nomura K., Sekoguchi S., Ueda K., Nakao M., Akano Y., Fujita Y., Yamashita Y., Horiike S., Nishida K., Nakamura S., Taniwaki M. Differentiation of follicular from mucosa-associated lymphoid tissue lymphoma by detection of t(14;18) on single-cell preparations and paraffin-embedded sections. Genes Chromosomes Cancer. 33:2002;213-216.
19. Nomura K., Yoshino T., Nakamura S., Akano Y., Tagawa H., Nishida K., Seto M., Nakamura S., Ueda R., Yamagishi H., Taniwaki M. Detection of t(11;18)(q21;q21) in marginal zone lymphoma of mucosa-associated lymphoid tissue type on paraffin-embeded tissue sections by using fluorescence in situ hybridization. Cancer Genet Cytogenet. 140:2003;49-54.
20. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 329:1993;987-994.
21. Cheson B.D., Horning S.J., Coiffier B., Shipp M.A., Fisher R.I., Connors J.M., Lister T.A., Vose J., Grillo-Lopez A., Hagenbeek A., Cabanillas F., Klippensten D., Hiddemann W., Castellino R., Harris N.L., Armitage J.O., Carter W., Hoppe R., Canellos G.P. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 17:1999;1244-1253.
22. Weisenburger D.D., Gascoyne R.D., Bierman P.J., Shenkier T., Horsman D.E., Lynch J.C., Chan W.C., Greiner T.C., Connors J.M., Vose J.M., Armitage J.O., Sanger W.G. Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma. Leuk Lymphoma. 36:2000;513-523.
23. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
24. Godon A., Moreau A., Talmant P., Baranger-Papot L., Genevieve F., Milpied N., Zandecki M., Avet-Loiseau H. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia. 17:2003;255-259.
25. Osborne C.K., Norton L., Young R.C., Garvin A.J., Simon R.M., Berard C.W., Hubbard S., DeVita V.T. Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survival. Blood. 56:1980;98-103.
26. Glick J.H., McFadden E., Costello W., Ezdinli E., Berard C.W., Bennett J.M. Nodular histiocytic lymphoma: factors influencing prognosis and implications for aggressive chemotherapy. Cancer. 49:1982;840-845.
27. Pezzella F., Gatter K.C., Mason D.Y., Bastard C., Duval C., Krajewski A., Turner G.E., Ross F.M., Clark H., Jones D.B. Bcl-2 protein expression in follicular lymphomas in absence of 14;18 translocation. Lancet. 336:1990;1510-1511.
28. Wong K.F., Chan J.K.C. Follicular lymphoma with trisomy 18 and over-expression of BCL2 in the absence of t(14;18)(q32;q21). Cancer Genet Cytogenet. 123:2000;52-54.
29. Bentz M., Werner C.A., Dohner H., Joos S., Barth T.F., Siebert R., Schroder M., Stilgenbauer S., Fischer K., Moller P., Lichter P. High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood. 88:1996;1437-1444.
30. Monni O., Joensuu H., Franssila K., Klefstrom J., Alitalo K., Knuutila S. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood. 90:1997;1168-1174.
31. Yunis J.J., Mayer M.G., Arnesen M.A., Aeppli D.P., Oken M.M., Frizzera G. BCLl-2 and other genomic alterations in the prognosis of large-cell lymphoma. N Engl J Med. 320:1989;1047-1054.
32. Offit K., Koduru P.R., Hollis R., Filippa D., Jhanwar S.C., Clarkson B.C., Chaganti R.S. 18q21 rearrangement in diffuse large cell lymphoma: incidence and clinical significance. Br J Haematol. 72:1989;178-183.
33. Gribben J.G., Freedman A.S., Neuberg D., Roy D.C., Blake K.W., Woo S.D., Grossbard M.L., Rabinowe S.N., Coral F., Freeman G.J., et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med. 325:1991;1525-1533.
34. Levine E.G., Arthur D.C., Frizzera G., Paterson B.A., Hurd D.D., Bloomfield C.D. Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma. Ann Intern Med. 108:1988;14-20.
35. Tilly H., Rossi A., Stamatoullas A., Lenormand B., Bigorgne C., Kunlin A., Monconduit M., Bastard C. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood. 84:1994;1043-1049.